The Optimization Strategies Customer Relationship Management On G Pharmaceutical Company Under The New Medical Reform

On May 9, 2015, the State Council issued " key tasks summary in 2014 and key assignments in 2015 to deepen the medical and health system," which "will change the scope of the pharmaceutical industry into health", "reform the drug pricing system", "national based medicine and the development of health insurance directory directory and other species by the price borne by the State " and " non-health insurance, group medicine reimbursement varieties, price liberalization market competition " and other reform that is undoubtedly the new medical reform policy changes of the key signs. With the new medical reform model in China has gradually established, implementation of the new medical reform program outright cancellation of the super-national treatment to multinational pharmaceutical companies innovator product separately priced, large medical industry intensified rectification plus a series of measures to promote, necessitating the entire pharmaceutical industry value chain restructuring and reengineering.Under the "public contract" model corporate profits dropped significantly, the increasingly serious compliance form, which are forcing pharmaceutical companies(especially multinational pharmaceutical companies) to make the necessary restructuring and integration in customer relationship management, marketing model, organizational structure, in order to adapt under the new changes in the market environment health policy. Therefore, building a well-ordered new customer relationship management, it is in the background of each of the new medical reform pharmaceutical companies focus on strategic issues urgent. In this paper, text analysis, case studies, comparative analysis, first the content and historical evolution of health care reform done carding system, then the relevant domestic and foreign research review and on the basis of reference to G Pharmaceutical(China) Company as an example, by G pharmaceutical(China) company’s comprehensive introduction and the advantages and disadvantages of the analysis, the system is discussed under the new health care reform environment, health reform policy in the price mechanism, market access, compliance form in terms of multinational pharmaceutical companies the actual impact. Then put forward the corresponding countermeasures from aspects tentative target consumer choice, improve the database, customer interaction, customer relationship management and evaluation on the basis of the above analysis. Discussion by China’s new medical reform background multinational pharmaceutical company’s customer relationship management, help to understand the effects of the practice of the new medical reform, medical reform under the new extended background G pharmaceutical company customer managementrelated research. The domestic pharmaceutical industry to achieve strategic upgrade and orderly development provide valuable experiences.